4
Changes in Ownership
FENNEC PHARMACEUTICALS INC. Filed Acc 0001468316-26-000008
Director sold 10,079 shares at $8.36 ($84,260)
- Director acquired 15,598 shares (option exercise)
- Director acquired 5,208 shares (grant or award)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Raykov Rosty · Director
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-03-02 | Exercise or conversion : show line 1 in the form 10b5-1 | +15,598 | $2.45 | $38,215 | 114,075 | D |
| 2026-03-02 | Sale : show line 2 in the form 10b5-1 | −10,079 | $8.36 | $84,260 | 103,996 | D |
| 2026-02-28 | Grant or award : show line 3 in the form 10b5-1 | +5,208 | 109,204 | D | ||
| Open-market sales · 10,079 sh · avg $8.36 · $84,260 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-03-02 | Exercise or conversion : show line 4 in the form 10b5-1 Stock Options | −15,598 | $2.45 | $38,215 | 1,587,390 | D |
Loading xslF345X05/form4-03032026_040301.xml…